Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays.

Next Previous
X
Search
Trial Profile

Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol valerate (Primary) ; Lutropin alfa (Primary) ; Progesterone (Primary) ; Triptorelin (Primary) ; Chorionic gonadotropin
  • Indications Ovarian hyperstimulation syndrome
  • Focus Therapeutic Use
  • Acronyms ERAMAD

    • Most Recent Events

    • 25 Oct 2016 Status changed from recruiting to completed.
    • 22 Feb 2012 Additional lead trial centres added as reported by European Clinical Trials Database.
    • 22 Feb 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-003250-34).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top